Skip to contentC
Chemed Corp
C
CHEChemed Corp Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$316.11M$316.11Mderivedno prior Q4 2020 on file Net Income$74.63M$74.63Mderived−34.4% vs Q4 2020 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$98,029,000−31.6% Operating Cash Flowderived$63,570,000−26.8% Free Cash Flowderived$49,367,000−30.2% Margins · derivedOperating margin31.0%
Net margin23.6%
ended Dec 31, 2021 · filed Feb 28, 2022 · 59 d after period end